OptimizeRx Corp Q1 2025 10-Q Filed
Ticker: OPRX · Form: 10-Q · Filed: May 13, 2025 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
OptimizeRx Q1 2025 10-Q is in. Financials look stable.
AI Summary
OptimizeRx Corp filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including changes in common stock, treasury stock, additional paid-in capital, and retained earnings. The company's fiscal year ends on December 31st.
Why It Matters
This filing provides investors with the latest financial snapshot of OptimizeRx Corp, crucial for understanding the company's performance and financial health in early 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-13 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 12-31 — Fiscal Year End (Defines the end of the company's annual financial reporting cycle.)
Key Players & Entities
- OptimizeRx Corp (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date
- 260 Charles Street, Suite 302, Waltham, MA 02453 (address) — Company's business and mailing address
FAQ
What were the specific changes in OptimizeRx Corp's Additional Paid-In Capital during the first quarter of 2025?
The filing indicates that Additional Paid-In Capital changed from $103,949,000 as of December 31, 2024, to $104,129,000 as of March 31, 2025.
How did OptimizeRx Corp's Retained Earnings change from the end of 2024 to the end of Q1 2025?
Retained Earnings increased from $10,973,000 as of December 31, 2024, to $11,310,000 as of March 31, 2025.
What was the value of OptimizeRx Corp's Common Stock as of March 31, 2025?
As of March 31, 2025, the value of Common Stock was $1,000.
Did OptimizeRx Corp have any Treasury Stock as of March 31, 2025?
Yes, OptimizeRx Corp had $1,000 in Treasury Stock as of March 31, 2025.
What is the business address for OptimizeRx Corp?
The business address for OptimizeRx Corp is 260 Charles Street, Suite 302, Waltham, MA 02453.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding OptimizeRx Corp (OPRX).